BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28317920)

  • 1. KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress.
    Hata M; Ikeda HO; Kikkawa C; Iwai S; Muraoka Y; Hasegawa T; Kakizuka A; Yoshimura N
    Sci Rep; 2017 Mar; 7():44873. PubMed ID: 28317920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases.
    Hata M; Ikeda HO
    Neural Regen Res; 2017 Aug; 12(8):1252-1255. PubMed ID: 28966635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuoroprotective efficacies by KUS121, a VCP modulator, on animal models of retinal degeneration.
    Hasegawa T; Muraoka Y; Ikeda HO; Tsuruyama T; Kondo M; Terasaki H; Kakizuka A; Yoshimura N
    Sci Rep; 2016 Aug; 6():31184. PubMed ID: 27503804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel VCP modulator KUS121 exerts renoprotective effects in ischemia-reperfusion injury with retaining ATP and restoring ERAD-processing capacity.
    Hata Y; Date R; Fujimoto D; Ikeda HO; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Kakizuka A; Mukoyama M; Kuwabara T
    Am J Physiol Renal Physiol; 2022 May; 322(5):F577-F586. PubMed ID: 35343850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A VCP modulator, KUS121, as a promising therapeutic agent for post-traumatic osteoarthritis.
    Saito M; Nishitani K; Ikeda HO; Yoshida S; Iwai S; Ji X; Nakahata A; Ito A; Nakamura S; Kuriyama S; Yoshitomi H; Murata K; Aoyama T; Ito H; Kuroki H; Kakizuka A; Matsuda S
    Sci Rep; 2020 Nov; 10(1):20787. PubMed ID: 33247195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of VCP modulators on gene expression profiles of retinal ganglion cells in an acute injury mouse model.
    Hasegawa T; Ikeda HO; Gotoh N; Iida K; Iwai S; Nakano N; Kakizuka A; Tsujikawa A
    Sci Rep; 2020 Mar; 10(1):4251. PubMed ID: 32144342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KUS121, a valosin-containing protein modulator, attenuates ischemic stroke via preventing ATP depletion.
    Kinoshita H; Maki T; Yasuda K; Kishida N; Sasaoka N; Takagi Y; Kakizuka A; Takahashi R
    Sci Rep; 2019 Aug; 9(1):11519. PubMed ID: 31395936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of VCP modulators in mouse models of glaucoma.
    Nakano N; Ikeda HO; Hasegawa T; Muraoka Y; Iwai S; Tsuruyama T; Nakano M; Fuchigami T; Shudo T; Kakizuka A; Yoshimura N
    Heliyon; 2016 Apr; 2(4):e00096. PubMed ID: 27441270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KUS121 attenuates the progression of monosodium iodoacetate-induced osteoarthritis in rats.
    Iwai S; Ikeda HO; Mera H; Nishitani K; Saito M; Tsujikawa A; Kakizuka A
    Sci Rep; 2021 Aug; 11(1):15651. PubMed ID: 34341460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel VCP modulators mitigate major pathologies of rd10, a mouse model of retinitis pigmentosa.
    Ikeda HO; Sasaoka N; Koike M; Nakano N; Muraoka Y; Toda Y; Fuchigami T; Shudo T; Iwata A; Hori S; Yoshimura N; Kakizuka A
    Sci Rep; 2014 Aug; 4():5970. PubMed ID: 25096051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective Effects of VCP Modulator KUS121 in Murine and Porcine Models of Myocardial Infarction.
    Ide Y; Horie T; Saito N; Watanabe S; Otani C; Miyasaka Y; Kuwabara Y; Nishino T; Nakao T; Nishiga M; Nishi H; Nakashima Y; Nakazeki F; Koyama S; Kimura M; Tsuji S; Rodriguez RR; Xu S; Yamasaki T; Watanabe T; Yamamoto M; Yanagita M; Kimura T; Kakizuka A; Ono K
    JACC Basic Transl Sci; 2019 Oct; 4(6):701-714. PubMed ID: 31709319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of C/EBP homologous protein in retinal ganglion cell death after ischemia/reperfusion injury.
    Nashine S; Liu Y; Kim BJ; Clark AF; Pang IH
    Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):221-31. PubMed ID: 25414185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoplasmic reticulum stress in retinal vascular degeneration: protective role of resveratrol.
    Li C; Wang L; Huang K; Zheng L
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):3241-9. PubMed ID: 22491413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferulic acid, but not tetramethylpyrazine, significantly attenuates retinal ischemia/reperfusion-induced alterations by acting as a hydroxyl radical scavenger.
    Chao HM; Lin DE; Chang Y; Hsu WM; Lee SM; Lee FL; Chi CW; Pan WH; Liu TY; Lui WY; Ho LT; Kuo CD; Chan CC; Chao FP
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):461-72. PubMed ID: 18788996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KUS121, a VCP modulator, has an ameliorating effect on acute and chronic heart failure without calcium loading via maintenance of intracellular ATP levels.
    Tsuji S; Otani C; Horie T; Watanabe S; Baba O; Sowa N; Ide Y; Kashiwa A; Makiyama T; Imai H; Nakashima Y; Yamasaki T; Xu S; Matsushita K; Suzuki K; Zou F; Kume E; Hasegawa K; Kimura T; Kakizuka A; Ono K
    Biomed Pharmacother; 2024 Jan; 170():115850. PubMed ID: 38091636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of rabbit retina from ischemic injury by flupirtine.
    Osborne NN; Schwarz M; Pergande G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):274-80. PubMed ID: 8603831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fewer Functional Deficits and Reduced Cell Death after Ranibizumab Treatment in a Retinal Ischemia Model.
    Palmhof M; Lohmann S; Schulte D; Stute G; Wagner N; Dick HB; Joachim SC
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia.
    Kapin MA; Doshi R; Scatton B; DeSantis LM; Chandler ML
    Invest Ophthalmol Vis Sci; 1999 May; 40(6):1177-82. PubMed ID: 10235551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of endothelins in neuroprotection of valosin-containing protein modulators against retinal ganglion cell damage.
    Kusaka M; Hasegawa T; Ikeda HO; Inoue Y; Iwai S; Iida K; Tsujikawa A
    Sci Rep; 2022 Sep; 12(1):16156. PubMed ID: 36171250
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.